Search

Your search keyword '"Padberg GW"' showing total 189 results

Search Constraints

Start Over You searched for: Author "Padberg GW" Remove constraint Author: "Padberg GW"
189 results on '"Padberg GW"'

Search Results

1. Vocational perspectives and neuromuscular disorders

2. THE CHOICE OF TREATMENT OF SINGLE BRAIN METASTASIS SHOULD BE BASED ON EXTRACRANIAL TUMOR-ACTIVITY AND AGE

3. The muscular dystrophies and dystrophin

4. THE INFLUENCE OF HANDEDNESS ON THE DISTRIBUTION OF MUSCULAR WEAKNESS OF THE ARM IN FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY

16. HYPOKALEMIC PERIODIC PARALYSIS AND THE DIHYDROPYRIDINE RECEPTOR (CACNLIA3) - GENOTYPE-PHENOTYPE CORRELATIONS FOR 2 PREDOMINANT MUTATIONS AND EVIDENCE FOR THE ABSENCE OF A FOUNDER EFFECT IN 16 CAUCASIAN FAMILIES

17. Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trial.

18. The other face of facioscapulohumeral muscular dystrophy: Exploring orofacial weakness using muscle ultrasound.

20. Noncoding variants alter GATA2 expression in rhombomere 4 motor neurons and cause dominant hereditary congenital facial paresis.

21. Facioscapulohumeral Disease as a myodevelopmental disease: Applying Ockham's razor to its various features.

22. 1st FSHD European Trial Network workshop:Working towards trial readiness across Europe.

23. Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations.

24. Ophthalmological findings in facioscapulohumeral dystrophy.

26. Variants affecting diverse domains of MEPE are associated with two distinct bone disorders, a craniofacial bone defect and otosclerosis.

27. Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy.

28. Phenotype-genotype relations in facioscapulohumeral muscular dystrophy type 1.

29. Experiences with bariatric surgery in patients with facioscapulohumeral dystrophy and myotonic dystrophy type 1: A qualitative study.

30. A 22-year follow-up reveals a variable disease severity in early-onset facioscapulohumeral dystrophy.

31. A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1.

32. Early onset facioscapulohumeral dystrophy - a systematic review using individual patient data.

33. Adding quantitative muscle MRI to the FSHD clinical trial toolbox.

34. Respiratory function in facioscapulohumeral muscular dystrophy 1.

35. What's in a name? The clinical features of facioscapulohumeral muscular dystrophy.

37. De novo mutations in PLXND1 and REV3L cause Möbius syndrome.

39. Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2.

40. Skeletal muscle imaging in facioscapulohumeral muscular dystrophy, pattern and asymmetry of individual muscle involvement.

41. Population-based incidence and prevalence of facioscapulohumeral dystrophy.

42. Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.

43. Determining the role of sarcomeric proteins in facioscapulohumeral muscular dystrophy: a study protocol.

44. Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD.

45. Sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy.

46. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2.

48. A unifying genetic model for facioscapulohumeral muscular dystrophy.

49. 171st ENMC international workshop: Standards of care and management of facioscapulohumeral muscular dystrophy.

50. Only fat infiltrated muscles in resting lower leg of FSHD patients show disturbed energy metabolism.

Catalog

Books, media, physical & digital resources